Eu Ivdd Eu Ivd Self Testing On The Market 🇨🇳 China

COVID-19 (SARS-CoV-2) Antigen Test Kit

Devices (same UDI-DI)
1
Certificates
1
Countries
0
Notified Bodies
1

Basic Information

Primary DI
06973720138404
Basic UDI-DI Code
B-06973720138404
Reference
W-AgH-20S
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd Self Testing
Status
On The Market

Additional Description

Brand name: Selfdiagnostics Type: B This kit is intended for in vitro qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasal swabs from individuals suspected of COVID-19. The kit is suitable for layperson use, children under age of 14 should be assisted by an adult. Please always seek for assistance and supervision with the test when needed and follow your local guidelines for specimen collection by children. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.

CND Nomenclature Codes

Code Description
W0105040619 CORONAVIRUS [obsolete from 2025-01-01]

Certificates

Type Number
IVDD Annex III Section 6 1434-IVDD-079/2022

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Self Testing) and regulation (EU IVDD).

View all